U.S. approves gene therapy treatment for hemophilia

26 avril 2024 | Agence France-Presse
Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
 Site référencé:  Raw Story

Raw Story 

GOP scorned for trying to hide budget vote under cover of night
3/07/2025
James Carville warns Trump could impose martial law before midterms
3/07/2025
'Gardeners ? Really ?' Joe Rogan breaks with Trump on 'insane' deportations
3/07/2025
Lawyer who shielded Ivanka Trump now issues dire warning about her dad
3/07/2025
MAGA lawmaker complains about being stuck in DC amid marathon filibuster by Dems
3/07/2025
'Are you rapping ?' GOP lawmaker smears Hakeem Jeffries' historic floor speech
3/07/2025